Prestige Wealth Management Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Prestige Wealth Management Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.14K	Hold	6	–	–	﹤0.01%	843
2025 Q4	$1.02K	Hold	6	–	–	﹤0.01%	867
2025 Q3	$791	Hold	6	–	–	﹤0.01%	886
2025 Q2	$637	Hold	6	–	–	﹤0.01%	909
2025 Q1	$745	Hold	6	–	–	﹤0.01%	892
2024 Q4	$739	Hold	6	–	–	﹤0.01%	927
2024 Q3	$669	Hold	6	–	–	﹤0.01%	932
2024 Q2	$641	Hold	6	–	–	﹤0.01%	901
2024 Q1	$723	Hold	6	–	–	﹤0.01%	911
2023 Q4	$738	Hold	6	–	–	﹤0.01%	892
2023 Q3	$777	Hold	6	–	–	﹤0.01%	913
2023 Q2	$744	Hold	6	–	–	﹤0.01%	942
2023 Q1	$878	Sell	6 -19	-76%	-$2.81K	﹤0.01%	906
2022 Q4	$3.98K	Buy	25 +19	+317%	+$2.79K	﹤0.01%	667
2022 Q3	$1K	Hold	6	–	–	﹤0.01%	861
2022 Q2	$1K	Hold	6	–	–	﹤0.01%	873
2022 Q1	$1K	Hold	6	–	–	﹤0.01%	886
2021 Q4	$1K	Hold	6	–	–	﹤0.01%	910
2021 Q3	$1K	Sell	6 -11	-65%	-$1.66K	﹤0.01%	898
2021 Q2	$3K	Buy	+17	New	+$2.94K	﹤0.01%	731

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prestige Wealth Management Group's JAZZ Position: Q1 2026 in Review

Prestige Wealth Management Group held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 6 shares worth $1.14K. The position accounts for ﹤0.01% of the portfolio, ranked #843.

Prestige Wealth Management Group first reported a position in JAZZ in Q2 2021 and has held it in 20 quarters since. The position peaked at $3.98K in Q4 2022. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Prestige Wealth Management Group held 6 shares of Jazz Pharmaceuticals worth $1.14K as of Q1 2026.
Prestige Wealth Management Group left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
Jazz Pharmaceuticals made up ﹤0.01% of Prestige Wealth Management Group's portfolio in Q1 2026, its #843 holding.
Prestige Wealth Management Group first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
Prestige Wealth Management Group's Jazz Pharmaceuticals position peaked at $3.98K in Q4 2022.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Prestige Wealth Management Group's 13F filing for Q1 2026, filed 13 May 2026.